The BMTF aims to provide an environment in which the existing research expertise from partners and collaborators will come together to create critical mass in collaborative multidisciplinary research teams, to develop new materials for devices, diagnostics, delivery technologies, imaging agents and the assessment of these materials through new, non-invasive, in situ imaging techniques.
Two biological isolator facilities have been established to facilitate clinical development of human cell-based therapies. Established under the auspices of the Victorian Consortium for Cell-based Therapies (VCCT), the isolators provide a complete barrier from environmental and operator-borne contamination and are therefore ideally suited for aseptic processing.
The Victorian Cancer Biobank is a not-for-profit consortium of tissue banks, supported by the Victorian Government through the Victorian Cancer Agency. Our purpose is to provide high quality, ethically obtained biospecimens to support research that will lead to improvements in cancer diagnosis and treatment.
The Australian Cancer Research Foundation (ACRF) Centre for Cancer Genomic Medicine is a newly established facility offering Next-Generation Sequencing. The centre will utilise the latest Life Technologies SOLiD 5500 and Ion Torrent systems in addition to complementary third generation sequencing systems.